Skip to main content

Peer Review reports

From: Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial

Original Submission
28 Mar 2024 Submitted Original manuscript
7 Apr 2024 Reviewed Reviewer Report
8 Apr 2024 Reviewed Reviewer Report
19 Apr 2024 Author responded Author comments - Brett Dabruzzo
29 Apr 2024 Author responded Author comments - Brett Dabruzzo
Resubmission - Version 2
19 Apr 2024 Submitted Manuscript version 2
Publishing
30 Apr 2024 Editorially accepted
21 May 2024 Article published 10.1186/s10194-024-01783-6

You can find further information about peer review here.

Back to article page